FDA Issues Draft Guidance On Advisory Panel Conflict Disclosures

FDA's issued a 1draft guidance Oct. 31 clarifying its process for publicizing FDA advisory panel members' potential conflicts-of-interest

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight